Literature DB >> 16563524

Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy.

Sebastiaan Overeem1, Jan J Verschuuren, Rolf Fronczek, Liesbeth Schreurs, Heleen den Hertog, Ingrid M Hegeman-Kleinn, Sjoerd G van Duinen, Unga A Unmehopa, Dick F Swaab, Gert Jan Lammers.   

Abstract

Most human patients with narcolepsy have no detectable hypocretin-1 in their cerebrospinal fluid. The cause of this hypocretin deficiency is unknown, but the prevailing hypothesis states that an autoimmune-mediated mechanism is responsible. We screened for the presence of autoantibodies against neurons in the lateral hypothalamus in 76 patients and 63 controls, using immunohistochemistry. Autoantibodies were present in two patients, but also in two controls. However, one of the patients had a clearly different staining pattern and nerve endings of immunolabeled cells were found to project onto hypocretin-producing neurons, suggesting a possible pathophysiological role. Humoral immune mechanisms appear not to play a role in the pathogenesis of narcolepsy, at least not in the clinically overt stage of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563524     DOI: 10.1016/j.jneuroim.2006.02.010

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.

Authors:  Stine Knudsen; Poul J Jennum; Jørgen Alving; Søren Paludan Sheikh; Steen Gammeltoft
Journal:  Sleep       Date:  2010-02       Impact factor: 5.849

Review 2.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

3.  Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy.

Authors:  Rolf Fronczek; Jan Verschuuren; Gert Jan Lammers
Journal:  J Neurol       Date:  2007-09-04       Impact factor: 4.849

Review 4.  Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment.

Authors:  Lucie Barateau; Roland Liblau; Christelle Peyron; Yves Dauvilliers
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

Review 5.  Challenges in the development of therapeutics for narcolepsy.

Authors:  Sarah Wurts Black; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

Review 6.  Immunotherapy in Narcolepsy.

Authors:  Maria Pia Giannoccaro; Giombattista Sallemi; Rocco Liguori; Giuseppe Plazzi; Fabio Pizza
Journal:  Curr Treat Options Neurol       Date:  2020-01-30       Impact factor: 3.598

7.  Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns.

Authors:  Peter Bergman; Csaba Adori; Szilvia Vas; Ylva Kai-Larsen; Tomi Sarkanen; Andreas Cederlund; Birgitta Agerberth; Ilkka Julkunen; Beata Horvath; Diana Kostyalik; Lajos Kalmár; Gyorgy Bagdy; Anne Huutoniemi; Markku Partinen; Tomas Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

8.  IgG abnormality in narcolepsy and idiopathic hypersomnia.

Authors:  Susumu Tanaka; Makoto Honda
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

Review 9.  Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder.

Authors:  Maria Pia Giannoccaro; Rocco Liguori; Giuseppe Plazzi; Fabio Pizza
Journal:  Nat Sci Sleep       Date:  2021-05-11

Review 10.  Narcolepsy and the hypocretin system--where motion meets emotion.

Authors:  Jerome M Siegel; Lisa N Boehmer
Journal:  Nat Clin Pract Neurol       Date:  2006-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.